343 related articles for article (PubMed ID: 19067777)
1. Elevated adiponectin serum levels in patients with chronic alcohol abuse rapidly decline during alcohol withdrawal.
Buechler C; Schäffler A; Johann M; Neumeier M; Köhl P; Weiss T; Wodarz N; Kiefer P; Hellerbrand C
J Gastroenterol Hepatol; 2009 Apr; 24(4):558-63. PubMed ID: 19067777
[TBL] [Abstract][Full Text] [Related]
2. Hyperadiponectinemia in alcoholic liver disease: friend or foe?
Adachi M; Ishii H
J Gastroenterol Hepatol; 2009 Apr; 24(4):507-8. PubMed ID: 19368631
[No Abstract] [Full Text] [Related]
3. Interferon therapy for chronic hepatitis C in habitual drinkers: comparison with chronic hepatitis C in infrequent drinkers.
Ohnishi K; Matsuo S; Matsutani K; Itahashi M; Kakihara K; Suzuki K; Ito S; Fujiwara K
Am J Gastroenterol; 1996 Jul; 91(7):1374-9. PubMed ID: 8677998
[TBL] [Abstract][Full Text] [Related]
4. Association of serum adipocytokines with insulin resistance and liver injury in patients with chronic hepatitis C genotype 4.
Khattab MA; Eslam M; Aly MM; Shatat M; Hussen A; Moussa YI; Elsaghir G; Abdalhalim H; Aly A; Gaber S; Harrison SA
J Clin Gastroenterol; 2012; 46(10):871-9. PubMed ID: 22664476
[TBL] [Abstract][Full Text] [Related]
5. Relative versus absolute carbohydrate-deficient transferrin as a marker of alcohol consumption in patients with acute alcoholic hepatitis.
Halm U; Tannapfel A; Mössner J; Berr F
Alcohol Clin Exp Res; 1999 Oct; 23(10):1614-8. PubMed ID: 10549992
[TBL] [Abstract][Full Text] [Related]
6. Rapid decline of liver stiffness following alcohol withdrawal in heavy drinkers.
Trabut JB; Thépot V; Nalpas B; Lavielle B; Cosconea S; Corouge M; Vallet-Pichard A; Fontaine H; Mallet V; Sogni P; Pol S
Alcohol Clin Exp Res; 2012 Aug; 36(8):1407-11. PubMed ID: 22404692
[TBL] [Abstract][Full Text] [Related]
7. Fibrosis is associated with adiponectin resistance in chronic hepatitis C virus infection.
Corbetta S; Redaelli A; Pozzi M; Bovo G; Ratti L; Redaelli E; Pellegrini C; Beck-Peccoz P; Spada A
Eur J Clin Invest; 2011 Aug; 41(8):898-905. PubMed ID: 21539538
[TBL] [Abstract][Full Text] [Related]
8. Serum miR-122 as a biomarker of necroinflammation in patients with chronic hepatitis C virus infection.
Bihrer V; Friedrich-Rust M; Kronenberger B; Forestier N; Haupenthal J; Shi Y; Peveling-Oberhag J; Radeke HH; Sarrazin C; Herrmann E; Zeuzem S; Waidmann O; Piiper A
Am J Gastroenterol; 2011 Sep; 106(9):1663-9. PubMed ID: 21606975
[TBL] [Abstract][Full Text] [Related]
9. Serum hyaluronate reflects hepatic fibrogenesis in alcoholic liver disease and is useful as a marker of fibrosis.
Parés A; Deulofeu R; Giménez A; Caballería L; Bruguera M; Caballería J; Ballesta AM; Rodés J
Hepatology; 1996 Dec; 24(6):1399-403. PubMed ID: 8938169
[TBL] [Abstract][Full Text] [Related]
10. Iron-related indexes in chronic alcoholics. Effect of alcohol withdrawal.
Conte D; Corsetti M; Colli A; Bardella MT; Cocciolo M; Fraquelli AM
Ital J Gastroenterol Hepatol; 1998 Oct; 30(5):534-8. PubMed ID: 9836113
[TBL] [Abstract][Full Text] [Related]
11. The interleukin-17 pathway is involved in human alcoholic liver disease.
Lemmers A; Moreno C; Gustot T; Maréchal R; Degré D; Demetter P; de Nadai P; Geerts A; Quertinmont E; Vercruysse V; Le Moine O; Devière J
Hepatology; 2009 Feb; 49(2):646-57. PubMed ID: 19177575
[TBL] [Abstract][Full Text] [Related]
12. Serum adiponectin in chronic hepatitis C and B.
Siagris D; Vafiadis G; Michalaki M; Lekkou A; Starakis I; Makri M; Margaritis V; Christofidou M; Tsamandas AC; Labropoulou-Karatza C
J Viral Hepat; 2007 Aug; 14(8):577-83. PubMed ID: 17650292
[TBL] [Abstract][Full Text] [Related]
13. Biomarkers of liver status in heavy drinkers, moderate drinkers and abstainers.
Alatalo P; Koivisto H; Puukka K; Hietala J; Anttila P; Bloigu R; Niemelä O
Alcohol Alcohol; 2009; 44(2):199-203. PubMed ID: 19054785
[TBL] [Abstract][Full Text] [Related]
14. Effect of alcohol consumption on the progression of hepatitis C virus infection and risk of hepatocellular carcinoma in Japanese patients.
Khan KN; Yatsuhashi H
Alcohol Alcohol; 2000; 35(3):286-95. PubMed ID: 10869250
[TBL] [Abstract][Full Text] [Related]
15. External validation of biochemical indices for noninvasive evaluation of liver fibrosis in HCV chronic hepatitis.
Iacobellis A; Mangia A; Leandro G; Clemente R; Festa V; Attino V; Ricciardi R; Giacobbe A; Facciorusso D; Andriulli A
Am J Gastroenterol; 2005 Apr; 100(4):868-73. PubMed ID: 15784034
[No Abstract] [Full Text] [Related]
16. Serum adiponectin correlates with viral characteristics but not histologic features in patients with chronic hepatitis C.
Liu CJ; Chen PJ; Jeng YM; Huang WL; Yang WS; Lai MY; Kao JH; Chen DS
J Hepatol; 2005 Aug; 43(2):235-42. PubMed ID: 15964656
[TBL] [Abstract][Full Text] [Related]
17. Serum levels of adipokines in patients with chronic HCV infection: relationship with steatosis and fibrosis.
Tiftikci A; Atug O; Yilmaz Y; Eren F; Ozdemir FT; Yapali S; Ozdogan O; Celikel CA; Imeryuz N; Tozun N
Arch Med Res; 2009 May; 40(4):294-8. PubMed ID: 19608019
[TBL] [Abstract][Full Text] [Related]
18. Serum cystatin C: a non-invasive marker of liver fibrosis or of current liver fibrogenesis in chronic hepatitis C? .
Ladero JM; Cárdenas MC; Ortega L; González-Pino A; Cuenca F; Morales C; Lee-Brunner A
Ann Hepatol; 2012; 11(5):648-51. PubMed ID: 22947524
[TBL] [Abstract][Full Text] [Related]
19. Alcohol intake modifies leptin, adiponectin and resistin serum levels and their mRNA expressions in adipose tissue of rats.
Pravdova E; Macho L; Fickova M
Endocr Regul; 2009 Jul; 43(3):117-25. PubMed ID: 19817506
[TBL] [Abstract][Full Text] [Related]
20. Antinuclear antibody is associated with a more advanced fibrosis and lower RNA levels of hepatitis C virus in patients with chronic hepatitis C.
Hsieh MY; Dai CY; Lee LP; Huang JF; Tsai WC; Hou NJ; Lin ZY; Chen SC; Wang LY; Chang WY; Chuang WL; Yu ML
J Clin Pathol; 2008 Mar; 61(3):333-7. PubMed ID: 17545561
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
